HNGE vs UNH vs CVS vs ELV vs KO

For growth investors, Hinge Health, Inc.

(HNGE) is the stronger pick with 50. 6% revenue growth year-over-year, versus 1. 9% for The Coca-Cola Company (KO). Elevance Health Inc. (ELV) offers the better valuation at 16. 1x trailing P/E (15. 1x forward), making it the more compelling value choice. Analysts rate Hinge Health, Inc. (HNGE) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Elevance Health Inc.

(ELV) is the cheapest at 16. 1x versus CVS Health Corporation at 73. 4x. On forward P/E, CVS Health Corporation is actually cheaper at 13. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Elevance Health Inc. wins at 2. 18x versus The Coca-Cola Company's 2. 26x.

Over the past 5 years, Hinge Health, Inc.

(HNGE) delivered a total return of +74. 0%, compared to +11. 7% for UnitedHealth Group Incorporated (UNH). Over 10 years, the gap is even starker: ELV returned +244. 7% versus CVS's +29. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.

20β versus Hinge Health, Inc. 's 1. 32β — meaning HNGE is approximately -762% more volatile than KO relative to the S&P 500. On balance sheet safety, Hinge Health, Inc. (HNGE) carries a lower debt/equity ratio of 2% versus 133% for The Coca-Cola Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hinge Health, Inc.

(HNGE) is pulling ahead at 50. 6% versus 1. 9% for The Coca-Cola Company (KO). On earnings-per-share growth, the picture is similar: The Coca-Cola Company grew EPS 23. 6% year-over-year, compared to -33. 6% for Hinge Health, Inc.. Over a 3-year CAGR, UNH leads at 11. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

The Coca-Cola Company (KO) is the more profitable company, earning 27.

3% net margin versus -89. 9% for Hinge Health, Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus -92. 9% for HNGE. At the gross margin level — before operating expenses — HNGE leads at 79. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Elevance Health Inc. (ELV) is the more undervalued stock at a PEG of 2. 18x versus The Coca-Cola Company's 2. 26x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, CVS Health Corporation (CVS) trades at 13. 8x forward P/E versus 26. 0x for Hinge Health, Inc. — 12. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HNGE: 13. 5% to $74. 18.

In this comparison, CVS (2.

6% yield), KO (2. 5% yield), UNH (2. 1% yield), ELV (1. 7% yield) pay a dividend. HNGE does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

20), 2. 5% yield, +121. 1% 10Y return). Both have compounded well over 10 years (KO: +121. 1%, HNGE: +74. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HNGE (Healthcare) and UNH (Healthcare) and CVS (Healthcare) and ELV (Healthcare) and KO (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HNGE is a small-cap high-growth stock; UNH is a large-cap quality compounder stock; CVS is a mid-cap quality compounder stock; ELV is a mid-cap deep-value stock; KO is a large-cap quality compounder stock. UNH, CVS, ELV, KO pay a dividend while HNGE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.